Buyback of Class B shares in Essity during week 50, 2025

Between December 8, 2025, and December 12, 2025, Essity Aktiebolag (publ) repurchased a total of 156,888 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.

The share purchase is part of the SEK 3bn buyback program announced by Essity on April 23, 2025. The buyback program will extend from April 24, 2025, until the 2026 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission’s Delegated Regulation 2016/1052 (Safe Harbour Regulation).

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity’s capital allocation.

Class B shares in Essity were repurchased as follows:

Date
Aggregated daily volume (no. of shares):
Weighted average price per day (SEK):
Total daily transaction value (SEK):
December 8, 2025
42,325
258.0057
10,920,091
December 9, 2025
41,339
258.9209
10,703,531
December 10, 2025
42,516
257.6927
10,956,063
December 11, 2025
17,444
257.7934
4,496,948
December 12, 2025
13,264
260.9853
3,461,709
Total accumulated during week 50 2025
156,888
258.3903
40,538,342
Total accumulated during the buyback program
9,092,425
258.3692
2,349,202,513

All purchases were conducted on Nasdaq Stockholm by BofA Securities Europe SA on behalf of Essity. Following the above purchases, Essity’s holding of treasury shares amounted on December 12, 2025, to 9,874,925 Class B shares. The total number of shares in Essity amounted on the date of this press release to 693,054,489, of which 58,346,658 Class A shares and 634,707,831 Class B shares.                                                        

For additional information, please contact:
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2024, Essity had net sales of approximately SEK 146bn (EUR 13bn) and employed 36,000 people. The company’s headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.

Läs mer på Cision

Ämnen i artikeln


Essity B

Senast

265,10

1 dag %

−0,38%

1 dag

1 mån

1 år

Essity A

Senast

264,50

1 dag %

−0,56%
Marknadsöversikt

1 DAG %

Senast

1 mån